AC Immune (ACIU) EBITDA Margin (2015 - 2026)
AC Immune (ACIU) reported EBITDA Margin of 1321.54% for Q1 2026, up 63503.0% year-over-year from N/an in Q1 2025, and up 68.97% on a QoQ basis from 4258.58% in Q4 2025.
AC Immune (ACIU) has 10 years of EBITDA Margin data on file, last reported at 1321.54% in Q1 2026.
- Quarterly EBITDA Margin rose 63503.0% year-over-year to 1321.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1749.24% (down 157246.0% YoY) and the FY2025 annual result came in at 1978.62%, down 178138.0% from the prior year.
- EBITDA Margin improved to 1321.54% in Q1 2026 per ACIU's latest filing, from 4258.58% in the prior quarter.
- Across five years, EBITDA Margin topped out at 28.52% in Q3 2024 and bottomed at 4258.58% in Q4 2025.
- The 4-year median for EBITDA Margin is 1637.47% (2024), against an average of 1749.79%.
- Peak annual rise in EBITDA Margin reached 156656 bps in 2025, while the deepest fall reached 262111 bps in 2025.
- Tracing ACIU's EBITDA Margin over 4 years: stood at 345.21% in 2022, then sank by 374 bps to 1637.47% in 2024, then tumbled by 160 bps to 4258.58% in 2025, then soared by 69 bps to 1321.54% in 2026.
- Per Business Quant, the three latest ACIU EBITDA Margin figures stand at 1321.54% (Q1 2026), 4258.58% (Q4 2025), and 1721.62% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | -1,321.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,321.54% |
| Dec 31, 2025 | -4,258.58% |
| Sep 30, 2025 | -1,721.62% |
| Jun 30, 2025 | -1,484.53% |
| Mar 31, 2025 | -1,956.57% |
| Dec 31, 2024 | -1,637.47% |
| Sep 30, 2024 | 28.52% |
| Jun 30, 2024 | -3,051.09% |
| Sep 30, 2022 | -345.21% |
| Dec 31, 2020 | -2,061.97% |
| Sep 30, 2020 | -1,674.53% |
| Jun 30, 2020 | -1,448.48% |
| Mar 31, 2020 | -59.46% |
| Dec 31, 2019 | -2,188.72% |
| Sep 30, 2019 | 817.14% |
| Jun 30, 2019 | -977.76% |
| Mar 31, 2019 | 80.16% |
| Dec 31, 2018 | -1,292.42% |
| Sep 30, 2018 | -528.03% |
| Jun 30, 2018 | -570.51% |
| Mar 31, 2018 | -776.54% |
| Dec 31, 2017 | 85.84% |
| Sep 30, 2017 | -1,678.80% |
| Jun 30, 2017 | -1,337.25% |
| Mar 31, 2017 | -390.53% |
| Dec 31, 2016 | 897.09% |
| Sep 30, 2016 | -621.23% |
| Mar 31, 2016 | -1,187.68% |
| Dec 31, 2015 | -992.92% |
| Sep 30, 2015 | 79.30% |